Article
Conformational Flexibility in Neutralization of SARS-CoV-2 by Naturally Elicited…
medRxiv · 2022 · Li, R.; Mor, M.; Ma, B.; Clark, A. E.; Alter, J.; Werbner, M.; Lee, J.; Leibel, S. L.; Carlin, A. F.; Dassau, M.; Gal-Tanamy, M.; Croker, B. A.; Xiang, Y.; Freund, N. T.
Key facts
| Title | Conformational Flexibility in Neutralization of SARS-CoV-2 by Naturally Elicited Anti-SARS-CoV-2 Antibodies |
|---|---|
| First author | Li, R.; Mor, M.; Ma, B.; Clark, A. E.; Alter, J.; Werbner, M.; Lee, J.; Leibel, S. L.; Carlin, A. F.; Dassau, M.; Gal-Tanamy, M.; Croker, B. A.; Xiang, Y.; Freund, N. T. |
| Journal | medRxiv |
| Published | Jul 4, 2022 |
| DOI | 10.1101/2022.04.03.486854 |
| Devices mentioned | K042152, K913963, K926106, K940422, K982100 |
| Product codes mentioned | CFN, DFZ, JLW, JNB |
At a glance
- 1–9 FDA submissions mentioned
- 1–9 Product codes mentioned
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About Literature
Peer-reviewed and preprint literature indexed by Orca1 and linked to the FDA submissions and product codes each article mentions. Only bibliographic details are shown here.
Source: Publisher and PubMed metadata; device mentions identified by Orca1